# neuro42

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuro42

- Industry: Medical Devices & Equipment
- Headquarters: San Francisco, US
- Website: www.neuro42.ai/
- Total disclosed funding: $13M
- Latest round: Series A (May 29, 2024)
- Investors on record: 3

## About

Founded in 2020 and based in California, US, neuro42, Inc. operates as a developer of magnetic resonance imaging technology and robotics for screening, diagnosis, and treatment of neurological diseases. In August 2024, the firm raised an amount of USD 6.65 million in venture funding from investor Zynext Ventures. As of 2024, the company is headed by its CEO Amit Vohra.

The flagship product of Neuro42 is a portable MRI platform that features advanced artificial intelligence and robotics. This platform facilitates screening, diagnosis, and live image-guided interventions with minimal setup and seamless integration into existing procedural workflows. The system aims to enhance both the patient and physician experience by providing high-quality imaging and operational efficiency.

The company plans to use the August 2024 funding to develop portable magnetic resonance imaging systems for neuroimaging and interventions.

## Funding rounds

- Series A, May 29, 2024, $6.7M — Zynext Ventures
- Series A, Jul 27, 2021, $6.5M — Zepp US Inc., ShangBay Capital

## Investors

- Zepp US Inc. — Series A
- ShangBay Capital (https://capitalatlas.ai/funds/shangbay-capital) — Series A
- Zynext Ventures (https://capitalatlas.ai/funds/zynext-ventures) — Series A